Results of a study published online in the American Journal of Sports Medicine show torn anterior cruciate ligaments (ACLs) treated with the Miach … continue reading “Bioengineered Repair Mimics Native ACL Says New Study”
Disposal allows MedShape to concentrate on core foot and ankle franchise
RTI will now offer a more pliable version of its Fortiva Tissue Matrix
Regenerative medicine platform technology has potential in areas beyond wound care
With Arthrex in its sights, Dallen Medical’s says its new button/plug dynamic fixation of Syndesmosis offers adjustability and claims its band is easier on surgeons’ hands
Arthrex has enhanced its position in provision of orthopaedic surgical technologies with the signing of a deal that sees it gain exclusive rights to the Cartiform chondral allograft.
Sports Med device maker Mitek’s gone all biotherapy on us with its newly announced launch of MONOVISC® High Molecular Weight Hyaluronan and the PEAK™ Platelet Rich Plasma (PRP) System
The CE marking of Aperion Biologics, Inc.’s lead product, the Z-Lig™ device makes it the first engineered biological device to gain approval for revision and multiligament ACL reconstruction.
Rotation Medical, Inc. tells us it has received U.S. FDA 510(k) clearance for its implantable collagen scaffold technology. The new technology is designed for use during arthroscopic and mini-open procedures to help support clinical management and protection of tendon injuries in which there has been no substantial loss of tendon tissue.
It looks like the courts are going to have to decide whether Cayenne Medical’s AperFix system has been infringed by MedShape’s ExoShape femoral soft tissue fastener. As usual, the devil will be in the detail, because face value tells us they look pretty similar.
Stryker Corporation is to acquire Pivot Medical, Inc., developer of innovative products for hip arthroscopy in a deal the details … continue reading “Stryker to Acquire Hip Arthroscopy Company, Pivot Medical”
Putting a few troubled years behind it, US Sports med, Spine and ENT device maker ArthroCare has been acquired by Smith and Nephew in a deal that values the Austin, Texas outfit at $1.7 Billion.
Last week we shared some pretty fiery correspondence that was made public by ConMed shareholder Voce Capital. Ten days later we see a response from ConMed, which has been filed with the SEC as part of the company’s fiduciary duty.
It’s been thought for over a decade that use of the anteromedial(AM) portal in ACL reconstruction is the best way of achieving an anatomical femoral socket, compared with drilling it through the tibial tunnel. Mitek sports medicine is showcasing its new purpose-designed Rigidfix® arc which facilitates Rigidfix cross pin fixation using the AM approach.
Shareholder are not always happy campers, but a new press release issued by one of ConMed’s institutional investors has been written in such a coruscatingly damning tone that we thought it worthy of presentation to our audience of cultured types who appreciate a bit of literary creativity. Not sure ConMed will be quite so appreciative.
A changing sales mix, the impact of the US sales tax and ongoing increased provision for potential settlement of outstanding alleged stock fraud all contributed to ArthroCare’s lower than predicted earnings. This, despite healthy top line sales growth in Q3.